text-size: + - R
JB Slider

Top News Stories

  • New Parkinson's Disease Drug ApprovedMore than 10 million people worldwide have Parkinson's disease (PD) and approximately 60,000 Americans are diagnosed with PD each year. The Food and Drug Administration (FDA) recently approved ...Read More
  • Hypertension Guidelines Consensus StatementThe American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) have collaborated to release updated hypertension practice guidelines. These guidelines specifically ...Read More
  • Novel Abuse-Deterrent Morphine ApprovedThe FDA recently approved Arymo ER (morphine sulfate extended-release) a novel abuse-deterrent opioid for chronic pain. Long-acting morphine in an abuse-deterrent formulation will decrease the ability...Read More
  • New Heart Failure GuidelinesThe American College of Cardiology (ACC), American Heart Association (AHA), and the Heart Failure Society of America (HFSA) recently updated the 2013 ACC/AHA guidelines for the management of heart ...Read More
  • New Eczema Drug ApprovedThe FDA recently approved a novel drug, crisaborole (Eucrisa), for the treatment of mild to moderate AD in adults and children greater than the age of two. This topical ointment is a phosphodiesterase...Read More
  • New Testosterone WarningsThe FDA recently approved label changes for all testosterone products to reflect new warnings of abuse and dependency. Prescribers will now be alerted by this new warning of potential abuse, adverse ...Read More
  • The Soaring Price of Epi-PenThe EpiPen® is a potential life-saving medication for patients who experience severe allergic reactions. The drug recently and dramatically spiked in price, drawing considerable national attention...Read More

Health Topics

View More Topics »